106 related articles for article (PubMed ID: 6157521)
1. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
Faure N; Cronin MJ; Martial JA; Weiner RI
Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
3. Absence of high affinity dopamine receptor in GH3 cells: a prolactin-secreting clone resistant to the inhibitory action of dopamine.
Cronin MJ; Faure N; Martial JA; Weiner RI
Endocrinology; 1980 Mar; 106(3):718-23. PubMed ID: 7353539
[TBL] [Abstract][Full Text] [Related]
4. Hypothyroid pituitary cells in culture: an analysis of thyrotropin and prolactin responses to dopamine (DA) and DA receptor binding.
Foord SM; Peters JR; Dieguez C; Jasani B; Hall R; Scanlon MF
Endocrinology; 1984 Jul; 115(1):407-15. PubMed ID: 6428863
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic stimulation of prolactin release.
Denef C; Manet D; Dewals R
Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
[TBL] [Abstract][Full Text] [Related]
6. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Woolf PD
Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
West B; Dannies PS
Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
[TBL] [Abstract][Full Text] [Related]
8. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
Foord SM; Peters JR; Dieguez C; Shewring G; Hall R; Scanlon MF
Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
Jaquet P; Gunz G; Grisoli F
Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
[TBL] [Abstract][Full Text] [Related]
11. Sodium ions: their role and mechanism of action in the control of prolactin release.
Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
Lafond J; Ducharme JR; Collu R
Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antagonistic regulation by estradiol and progesterone of the rat pituitary domperidone binding sites: correlation with ovarian steroid regulation of the dopaminergic inhibition of prolactin secretion in vitro.
Bression D; Brandi AM; Pagesy P; Le Dafniet M; Martinet M; Brailly S; Michard M; Peillon F
Endocrinology; 1985 May; 116(5):1905-11. PubMed ID: 3987624
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
15. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion.
Shah GV; Shyr SW; Grosvenor CE; Crowley WR
Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
[TBL] [Abstract][Full Text] [Related]
17. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
Day RN; Hinkle PM
Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fischer 344 rats.
Elias KA; Weiner RI
Endocrinology; 1987 Feb; 120(2):617-21. PubMed ID: 3803294
[TBL] [Abstract][Full Text] [Related]
19. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
Demarest KT; Moore KE; Riegle GD
Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
[TBL] [Abstract][Full Text] [Related]
20. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
